TY - JOUR
T1 - Cardiac lipid accumulation associated with diastolic dysfunction in obese mice
AU - Christoffersen, Christina
AU - Bollano, Entela
AU - Lindegaard, Marie L S
AU - Bartels, Emil D
AU - Goetze, Jens P
AU - Andersen, Claus B
AU - Nielsen, Lars B
PY - 2003/8
Y1 - 2003/8
N2 - Obesity may confer cardiac dysfunction due to lipid accumulation in cardiomyocytes. To test this idea, we examined whether obese ob/ob mice display heart lipid accumulation and cardiac dysfunction. Ob/ob mouse hearts had increased expression of genes mediating extracellular generation, transport across the myocyte cell membrane, intracellular transport, mitochondrial uptake, and beta-oxidation of fatty acids compared with ob/+ mice. Accordingly, ob/ob mouse hearts contained more triglyceride (6.8 +/- 0.4 vs. 2.3 +/- 0.4 microg/mg; P < 0.0005) than ob/+ mouse hearts. Histological examinations showed marked accumulation of neutral lipid droplets within cardiac myocytes but not increased deposition of collagen between myocytes in ob/ob compared with ob/+ mouse hearts. On echocardiography, the ratio of E to A transmitral flow velocities (an indicator of diastolic function) was 1.8 +/- 0.1 in ob/ob mice and 2.5 +/- 0.1 in ob/+ mice (P = 0.0001). In contrast, the indexes of systolic function and heart brain natriuretic peptide mRNA expression were only marginally affected and unaffected, respectively, in ob/ob compared with ob/+ mice. The results suggest that ob/ob mouse hearts have increased expression of cardiac gene products that stimulate myocyte fatty acid uptake and triglyceride storage and accumulate neutral lipids within the cardiac myocytes. The results also suggest that the cardiac lipid accumulation is paralleled by cardiac diastolic dysfunction in ob/ob mice.
AB - Obesity may confer cardiac dysfunction due to lipid accumulation in cardiomyocytes. To test this idea, we examined whether obese ob/ob mice display heart lipid accumulation and cardiac dysfunction. Ob/ob mouse hearts had increased expression of genes mediating extracellular generation, transport across the myocyte cell membrane, intracellular transport, mitochondrial uptake, and beta-oxidation of fatty acids compared with ob/+ mice. Accordingly, ob/ob mouse hearts contained more triglyceride (6.8 +/- 0.4 vs. 2.3 +/- 0.4 microg/mg; P < 0.0005) than ob/+ mouse hearts. Histological examinations showed marked accumulation of neutral lipid droplets within cardiac myocytes but not increased deposition of collagen between myocytes in ob/ob compared with ob/+ mouse hearts. On echocardiography, the ratio of E to A transmitral flow velocities (an indicator of diastolic function) was 1.8 +/- 0.1 in ob/ob mice and 2.5 +/- 0.1 in ob/+ mice (P = 0.0001). In contrast, the indexes of systolic function and heart brain natriuretic peptide mRNA expression were only marginally affected and unaffected, respectively, in ob/ob compared with ob/+ mice. The results suggest that ob/ob mouse hearts have increased expression of cardiac gene products that stimulate myocyte fatty acid uptake and triglyceride storage and accumulate neutral lipids within the cardiac myocytes. The results also suggest that the cardiac lipid accumulation is paralleled by cardiac diastolic dysfunction in ob/ob mice.
KW - Animals
KW - Apolipoproteins B/genetics
KW - Carrier Proteins/genetics
KW - Collagen/analysis
KW - Diastole/physiology
KW - Echocardiography
KW - Fatty Acid Transport Proteins
KW - Fatty Acids/metabolism
KW - Gene Expression
KW - Leptin/deficiency
KW - Lipid Metabolism
KW - Lipoprotein Lipase/genetics
KW - Membrane Proteins/genetics
KW - Membrane Transport Proteins
KW - Mice
KW - Mice, Knockout
KW - Mice, Obese
KW - Microscopy, Electron
KW - Mitochondria, Heart/metabolism
KW - Myocardium/chemistry
KW - Natriuretic Peptide, Brain/genetics
KW - Obesity/physiopathology
KW - Oxidation-Reduction
KW - Phosphatidylcholines/analysis
KW - Phosphatidylinositols/analysis
KW - RNA, Messenger/analysis
KW - Systole/physiology
KW - Triglycerides/analysis
U2 - 10.1210/en.2003-0242
DO - 10.1210/en.2003-0242
M3 - Journal article
C2 - 12865329
SN - 0013-7227
VL - 144
SP - 3483
EP - 3490
JO - Molecular Endocrinology
JF - Molecular Endocrinology
IS - 8
ER -